Publicaciones (32) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. Applications of Non-Coding RNAs in Patients With Retinoblastoma

    Frontiers in Genetics, Vol. 13

  2. Assessing the Utility and Patient Satisfaction of Virtual Retina Clinics During COVID-19 Pandemic

    Clinical Ophthalmology, Vol. 16, pp. 311-321

  3. Atypical acute fovealitis in COVID-19 context

    American Journal of Ophthalmology Case Reports, Vol. 27

  4. BACILLARY LAYER DETACHMENT OVERLYING REDUCED CHORIOCAPILLARIS FLOW in ACUTE IDIOPATHIC MACULOPATHY

    Retinal Cases and Brief Reports, Vol. 16, Núm. 1, pp. 59-66

  5. Bacillary layer detachment in a patient with serpiginoid choroiditis

    Indian Journal of Ophthalmology, Vol. 70, Núm. 7, pp. 2687-2689

  6. CHARACTERIZING COVID-19-RELATED RETINAL VASCULAR OCCLUSIONS: A Case Series and Review of the Literature

    Retina (Philadelphia, Pa.), Vol. 42, Núm. 3, pp. 465-475

  7. Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2

    Ocular Immunology and Inflammation, Vol. 30, Núm. 7-8, pp. 2010-2013

  8. Clinical Features and Outcomes of Tubulointerstitial Nephritis and Uveitis Syndrome in Spain and Portugal: The IBERTINU Project

    Ocular Immunology and Inflammation, Vol. 31, Núm. 2, pp. 286-291

  9. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

    Clinical and Experimental Ophthalmology, Vol. 50, Núm. 3, pp. 312-324

  10. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

  11. Factores de riesgo asociados al error refractivo residual tras cirugía de catarata en práctica clínica. Estudio observacional retrospectivo

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 3, pp. 140-148

  12. Guía de recomendaciones para el manejo de brolucizumab

    Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 11, pp. 626-638

  13. Incidence and Risk Factors Affecting the Recurrence of Primary Retinal Detachment in a Tertiary Hospital in Spain

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  14. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

    Ophthalmology Retina, Vol. 6, Núm. 11, pp. 1044-1053

  15. Individuals with heterozygous variants in the Wnt-signalling pathway gene FZD5 delineate a phenotype characterized by isolated coloboma and variable expressivity

    Ophthalmic genetics, Vol. 43, Núm. 6, pp. 809-816

  16. Ischemic Optic Neuropathy After Administration of a SARS-CoV-2 Vaccine: A Report of 2 Cases

    American Journal of Case Reports, Vol. 23, Núm. 1

  17. Late recurrence of choroidal neovascularization in patients with multifocal choroiditis: Clinical surveillance in perpetuity

    Retinal Cases and Brief Reports, Vol. 16, Núm. 2, pp. 233-241

  18. MULTIMODAL IMAGING of A PRESUMED EMBOLIC CILIORETINAL ARTERY OCCLUSION

    Retinal Cases and Brief Reports, Vol. 16, Núm. 2, pp. 141-144

  19. Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study

    Proteomes, Vol. 10, Núm. 1

  20. Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens

    Vision (Switzerland), Vol. 6, Núm. 1